Dr. Joan-Albert Vericat

Short CV

Carrer:

• July 2003 – Appointed as Director of Preclinical Development at Neuropharma SA.
• September 2002 – July 2003 – Head to Toxicology, J.Uriach & Cia, Palau de Plegamans (Barcelona), Spain.
• January 1996 – September 2002 – Head of the Research Group in Exploratory and Genetic Toxicology, Sanofi-Synthelabo (former Synthelabo Recherche; currently Sanofi-Aventis), Porcheville, France.
• July 1989 – December 1995 – Head of Genetic and Cellular Toxicology, Research Toxicology Centre, S.p.A., Pomezia (Roma), Italy.
• September 1987 – July 1989 – Postdoctoral Scientist at Bionetics Research, Inc, Frederick, Maryland, USA.
• 1981- September 1987 – Different posts (from graduate student up to non-permanent professor) in Department of Genetics and Microbiology in the Autonomous University of Barcelona (Spain).

Universitary Education:

• June 1983, Doctor in Sciences (Biology), Autonomous University of Barcelona, Bellaterra (Barcelona), Spain. The thesis project was: "Differential Expression of the SOS Repair System in Enterobacteriaceae". Qualification: "Cum Laude" ("A with honors"). Supervisor: Dr. J. Barbé, Department of Microbiology.
• November 1980, Master Degree in Biology, Autonomous University of Barcelona, Bellaterra (Barcelona), Spain.
• June 1979, Degree in Biology (Microbiology and Molecular Biology), Autonomous University of Barcelona, Bellaterra (Barcelona), Spain.

Other merits:

• President of the In Vitro Testing Industrial Platform (www.ivtip.org; until May 2008)
• Member of the Executive Board and Responsible of the Working Group on Regulatory Affaires of the European Technology Platform in Nanomedicines
• Member of the Board of REMA
• Member of the Board of the Spanish Mirror platforms in New Medicines and in Nanomedicines
• Referee in several journals: Toxicology Letters, Toxicology in vitro, Regulatory Toxicology & Pharmacology, Pharmacogenomics, etc.
• Paricipation as an invited expert in different EU  and USA workshops
• Member of the Board of an EC Integrated Project (Acutetox)
• Members of the Scientific Advisory Board of an EC Integrated Project (Reprotect)
• Member of the Scientific Advisory Board of the Spanish CIBER-BBN (Bioengineering and Imaging, Biomaterials and Tissue engineering, and Nanomedicines).
• Scientific articles in peer-reviewed journals
• Guest Editor for the special issue of Toxicology Letters 186(1) on Toxicogenomics and Clinical Toxicology, April 2009.

Languages:

Spanish, English, French, Italian.